by Riley Nolan | Jun 14, 2021 | Featured, Thinking Out Loud -Blog
The Curious Case of HCP-driven Immunogenicity The FDA briefly “paused” the Johnson & Johnson adenovirus-based COVID-19 vaccine in April, and the AstraZeneca vaccine (also adenovirus-based) was in the news as early as March. Both of these pauses were to...
by Annie De Groot | Jul 8, 2014 | Featured, News
New Immunogenicity Analysis Tool Emerges from Dartmouth-EpiVax-URI Collaboration “In Silico” Host Cell Protein for Protein Therapeutics Providence, RI. Tuesday, July 8th, 2014 A Public-private partnership resulted in the development of a new web-based tool that will...
by Annie De Groot | Sep 11, 2013 | Events
Dr. Annie De Groot is an invited speaker at the 6th Workshop on Monoclonal Antibodies in Basel, Switzerland, on September 12th, 2013. She will presenting information on CHO host cells proteins (HPC’s) and their effects on the immunogenicity of biologics. She...
by Annie De Groot | Jun 3, 2013 | Events
Measurement of Residual Host Cell Protein and DNA in Biotechnology Products Work Shop On Monday, June 3rd at 2:35 PM EpiVax’s CEO/CSO Dr. Annie De Groot presented a talk on the Immunogenicity Analysis of CHOP Contaminants in Therapeutic Protein Formulations. The...
by Annie De Groot | Oct 28, 2012 | Thinking Out Loud -Blog
Does Similarity Between Self and Non-Self Influence Immunogenicity? What is the impact of CHO (Chinese Hamster Ovary) Host Cell Proteins in Therapeutic Protein Formulations? New information emerging from a collaboration between Chris Bailey-Kellog, Andres Gutierrez,...
